Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Mechanism of San Jie Tong Mai Formula Against Atherosclerosis via Network Pharmacology and Proteomics.

Journal of visualized experiments : JoVE·2026
Same author

Research on the implementation path of digital-intelligent healthcare based on the TAM model from the perspective of high-quality development.

BMC health services research·2026
Same author

Reprogramming Postablation Tumor Immune Microenvironment with Dual-Function Nanotherapeutic Immunomodulator for Synergistic Antitumor Immunity and Recurrence Suppression.

ACS nano·2026
Same author

In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy.

Nature materials·2026
Same author

Immune checkpoint inhibition and heart injury: molecular mechanisms and clinical challenges.

ESC heart failure·2026
Same author

STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence.

Science advances·2026

Related Experiment Video

Updated: Jul 15, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Lipid-based nanoparticles for cancer immunotherapy.

Shumin Fan1, Huize Han1, Zhicheng Yan1

  • 1Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.

Medical Review (2021)
|October 4, 2023
PubMed
Summary

Lipid-based nanoparticles enhance cancer immunotherapy by overcoming the immunosuppressive tumor microenvironment. These nanomedicines improve drug delivery and immune cell targeting for more effective cancer treatment.

Keywords:
T cellscancer immunity cyclecancer immunotherapylipid-based nanoparticlesmacrophages

More Related Videos

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.9K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K

Related Experiment Videos

Last Updated: Jul 15, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.9K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K

Area of Science:

  • Oncology
  • Nanotechnology
  • Immunology

Background:

  • Cancer immunotherapy offers durable antitumor effects but faces limitations due to patient response variability and immune-related adverse events.
  • The immunosuppressive tumor microenvironment is a key factor causing immune evasion and blocking the cancer immunity cycle, hindering therapeutic efficacy.
  • Nanotechnology offers solutions to improve therapeutic efficacy and reduce toxicity by controlling drug biodistribution and release.

Purpose of the Study:

  • To review lipid-based nanoparticles for cancer immunotherapy applications.
  • To highlight T cell-activated and macrophage-targeted delivery systems.
  • To discuss how these nanoparticles can overcome immunosuppression and promote anti-tumor responses.

Main Methods:

  • Review of existing lipid-based nanoparticles in research and clinical markets.
  • Analysis of nanoparticle strategies for enhancing cancer immunity cycle steps.
  • Focus on targeted delivery systems for immune cells.

Main Results:

  • Lipid-based nanoparticles are a clinically translated nanomedicine platform with diverse applications.
  • These nanoparticles can be engineered for spatiotemporal control of therapeutic cargos.
  • Targeted delivery systems can enhance T cell activation and macrophage function.

Conclusions:

  • Lipid-based nanoparticles show promise in overcoming the challenges of current cancer immunotherapies.
  • By modulating the tumor microenvironment and enhancing immune cell activity, they can improve treatment outcomes.
  • Further development of targeted lipid-based nanoparticles is crucial for advancing cancer immunotherapy.